Dear Colleagues and Friends,
We are reaching out to let you know that abstract submission for the second Keystone Symposium on Drug Delivery to the Brain is now officially open!
https://www.keystonesymposia.org/conferences/conference-listing/meeting?eventid=7088
We are also delighted to share that Robert Thorne from Denali will be delivering the opening keynote lecture, which we are sure will set the stage for thought-provoking discussions. The full scientific program covers a broad range of established and emerging brain delivery modalities. You can find the program:
https://www.keystonesymposia.org/conferences/conference-listing/meeting/onpage-program/Q42025
In each session, several short talks will be chosen from the submitted abstracts, providing a great opportunity for speakers at all career stages to showcase their latest research. November 14th is the submission deadline in order to have your abstract considered for a short podium talk. We encourage each of you to attend and to consider submitting an abstract for a poster or podium presentation. Sessions will cover diverse areas, from innovative shuttle, viral, nanoparticle, exosome and ultrasound brain delivery platforms, to preclinical, translational and therapeutic delivery strategies. To help further expand the frontiers of treatment for brain disorders, our symposium is held concurrently with the joint symposium Antibodies as Drugs: Innovative Formats, Design and Engineering. Attendees with have full access to both of these conferences.
We look forward to seeing many familiar faces and to welcoming new ones as we come together to explore the latest breakthroughs in drug delivery to the brain.
Warm regards,
Stina Syvänen and James Gorman